Theodore Karrison

3Health Studies, and

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1

Top 100%

0DataRank

Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Papers

Driven by 30 papers — median percentile 0. Top paper: “Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation”.

Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation

Cancer Research(2005)10.1158/0008-5472.can-04-2490

N/A

8.3DataRank · unranked

163 citations

Mitchell C. Posner, James O. Park, Thomas E. Darga, Masha Kocherginsky, Theodore Karrison +6 more

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases

Journal of Clinical Investigation(2023)10.1172/jci162260

N/A

1.1DataRank · unranked

22 citations

Benjamin E. Onderdonk, Rebekah Dadey, Jared H. Hara, Lilit Karapetyan, Yuanyuan Zha +8 more

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.333

N/A

1.0DataRank · unranked

11 citations

Theodore Karrison, Oliver Sartor, Leonard G. Gomella, Mahul B. Amin, James A. Purdy +15 more

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

BMC Cancer(2022)10.1186/s12885-021-09146-z

N/A

0.654DataRank · unranked

18 citations

Evgeny Izumchenko, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair, Theodore Karrison +14 more

Impaired replication dynamics at the FRA3B common fragile site

Human Molecular Genetics(2010)10.1093/hmg/ddp470

N/A

0.542DataRank · unranked

36 citations

Isabelle Lucas, Yanwen Jiang, David J. Young, Anthony A. Fernald, Theodore Karrison +2 more

Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview

Current Pediatrics Reports(2022)10.1007/s40124-022-00269-w

N/A

0.528DataRank · unranked

12 citations

Kanix Wang, Aliya Moreira, Andrew Grose, Karen Leahy, Ying Zhou +95 more

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4604

N/A

0.464DataRank · unranked

21 citations

Theodore Karrison, Bradley A. McGregor, Pedro C. Barata, Himanshu Nagar, Chad Tang +10 more

Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils

Neuro-Oncology(2024)10.1093/neuonc/noae005

N/A

0.416DataRank · unranked

15 citations

Daniel L. Schwartz, Theodore Karrison, James J. Dignam, Mei‐Yin C. Polley

High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07515-3

N/A

0.330DataRank · unranked

8 citations

Christine Y. Shiang, Deniz Nesli Dolcen, Marie Dreyer, Ken Hatogai, Katie Hall +8 more

INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps179

N/A

0.292DataRank · unranked

6 citations

Theodore Karrison, C.A. Lawton, William A. Hall, Hala T. Borno, Mihaela Roşu +8 more

The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.05.048

N/A

0.252DataRank · unranked

4 citations

Theodore Karrison, Seth A. Rosenthal, Mahul B. Amin, Leonard G. Gomella, James A. Purdy +15 more

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4561

N/A

0.241DataRank · unranked

4 citations

Bryan Peterson, Leah M. Chase, Samantha Lomnicki, Anthony V. Serritella, Natalie Reizine +12 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13103

N/A

0.208DataRank · unranked

3 citations

Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn, Frederick M. Howard +8 more

Phase II study of pembrolizumab plus mifepristone in patients with advanced HER2-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1095

N/A

0.104DataRank · unranked

1 citations

Elena Michaels, Poornima Saha, Murtuza Rampurwala, Olwen Hahn, Frederick M. Howard +5 more

Scaling and interpreting treatment effects in clinical trials using restricted mean survival time

Clinical Trials(2024)10.1177/17407745241254995

N/A

0DataRank · unranked

1 citations

Chen Hu, James J. Dignam, Theodore Karrison

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Annals of Oncology(2025)10.1016/j.annonc.2025.01.017

N/A

0DataRank · unranked

16 citations

Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski +28 more

Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.001

N/A

0DataRank · unranked

8 citations

Ernst Lengyel, Andrea E. Wahner Hendrickson, Gustavo C. Rodriguez, Charles A. Leath, Rodney P. Rocconi +6 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07626-5

N/A

0DataRank · unranked

2 citations

Margarite D. Matossian, Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn +8 more

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.399

N/A

0DataRank · unranked

3 citations

Marla Johnson, J. Proudfoot, Elai Davicioni, Alan Dal Pra, Jeff Simko +15 more

Impact of First‐of‐Its‐Kind Patient‐Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3747

N/A

0DataRank · unranked

0 citations

Sami Elahi, Matthew Jack, John Campbell, Emily Smith, Randall W. Knoebel +11 more

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19

medRxiv(2020)10.1101/2020.07.20.20157503

N/A

0DataRank · unranked

26 citations

Brian L. Heiss, Sherin J. Rouhani, Jonathan Trujillo, Jovian Yu, Alec Kacew +18 more

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

Cancer Discovery(2020)10.1158/2159-8290.cd-20-1408

N/A

0DataRank · unranked

71 citations

Stephanie Moya, Samantha Lomnicki, Leah M. Chase, Bryan Peterson, Natalie Reizine +19 more

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease

Cancer(2022)10.1002/cncr.34263

N/A

0DataRank · unranked

13 citations

Mark A. Applebaum, Theodore Karrison, Akosua Y. Oppong, Cindy Yuan, Katherine R. Berg +14 more

Assessing response to neoadjuvant docetaxel and trastuzumab in Nigerian women with HER2-positive breast cancer (ARETTA).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps622

N/A

0DataRank · unranked

0 citations

Omoba Temitayo Adeniji-Sofoluwe, Anthonia Sowunmi, Ayorinde Folasire, Olalekan Olasehinde, AbdulRazzak Lawaal +16 more

Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens

Carcinogenesis(2020)10.1093/carcin/bgaa027

N/A

0DataRank · unranked

13 citations

Karin Schreiber, Elizabeth Hyjek, Thomas Krausz, Michael T. Spiotto, Madeline Steiner +17 more

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1

Top 100%

0DataRank

Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

A CBTH intervention for reducing stress in women with high risk in a DCE-MRI breast cancer screening study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e22507

N/A

0DataRank · unranked

0 citations

Ilona Siljander, Theodore Karrison, Yan Che, Judith Ovunwo, Arnaaz Khwaja +3 more

Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12022

N/A

0DataRank · unranked

0 citations

Theodore Karrison, Alan Pollack, Alexander G. Balogh, Deborah Watkins Bruner, Leonard G. Gomella +14 more

Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care

Journal of Pain Research(2024)10.2147/jpr.s488416

N/A

0DataRank · unranked

2 citations

Theodore Karrison, Matthew Jack, Anish Choksi, Randall W. Knoebel, Kiang-Teck J Yeo +6 more

Theodore Karrison

Indexed papers

Top data-sharing exemplar

Papers